Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Expedio Hereditary Cancer Predisposition Screening Assay Kailos Genetics United States | 40 | 31 |
|
Hereditary Breast and Ovarian Cancer Panel QDx Pathology Services, Inc. United States | 3 | 23 |
|
QDx Pathology Services, Inc. United States | 15 | 44 |
|
Hereditary Breast and Ovarian Cancer Panel Clariti Diagnostics Laboratories LLC United States | 3 | 23 |
|
Clariti Diagnostics Laboratories LLC United States | 15 | 44 |
|
Personalis, Inc. United States | 1 | 269 |
|
Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 47 | 41 |
|
Hereditary Cancer Screening - Breast & Gynecological Cancer Panel (33 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 37 | 33 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
RAD50 Gene Hereditary breast and ovarian cancer syndrome, RAD50 related NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 60 | 34 |
|
Tempus Labs, Inc. United States | 2 | 647 |
|
Otogenetics Hereditary Cancers Otogenetics United States | 36 | 39 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
OnkoSight Advanced Breast Cancer Panel BioReference Health United States | 1 | 50 |
|
Centogene AG - the Rare Disease Company Germany | 58 | 28 |
|
Centogene AG - the Rare Disease Company Germany | 113 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
RAD50 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.